Total 65Articles, Present Page 1/7
-
65Advisory Meeting Outcomes on Moderna COVID-19 Vaccine [Press Release, May 10, 2021]
-
(5.10) Advisory Meeting Outcomes on Moderna COVID-19 Vaccine.pdf
2021-05-11 -
-
64MFDS Begins Rolling Review of Sputnik V COVID-19 Vaccine [Press Release, April 29, 2021]
-
(4.29) MFDS Begins Roling Review of Sputnik V COVID-19 Vaccine.pdf
2021-05-03 -
-
63MFDS Begins Rolling Review of Novavax COVID-19 Vaccine [Press Release, April 29, 2021]
-
(4.29) MFDS Begins Rolling Review of Novavax COVID-19 Vaccine.pdf
2021-05-03 -
-
62MFDS Publishes Q&A Guidance on Development of COVID-19 Therapeutics & Vaccines [Press Release for Reference, April 30, 2021]
-
(4.30) MFDS Publishes Q&A Guidance on Development of COVID-19 Therapeutics & Vaccines.pdf
2021-04-30 -
-
61MFDS begins Review of Moderna COVID-19 Vaccine [Press Release, April 12, 2021]
-
(4.12) MFDS Begins Review of Moderna COVID-19 Vaccine.pdf
2021-04-13 -
-
60MFDS Grants Marketing Authorization for Janssen COVID-19 Vaccine [Press Release, April 7, 2021]
-
(4.7) MFDS Grants Marketing Authorization for Janssen COVID-19 Vaccine.pdf
2021-04-08 -
-
59MFDS Holds a Consultation Meeting to Support COVID-19 Vaccine Quality Management [Reference for Press Release, Apr. 6, 2021]
-
(4.6) MFDS Holds a Consultation Meeting to Support COVID-19 Vaccine Quality Management.pdf
2021-04-06 -
-
58Central Pharmaceutical Advisory Meeting Outcomes on Janssen COVID-19 Vaccine [Press Release, April 1, 2021]
-
(4.1) Central Pharmaceutical Advisory Meeting Outcomes on Janssen COVID-19 Vaccine.pdf
2021-04-02 -
-
57Advisory Committee Meeting Outcomes on Janssen COVID-19 Vaccine [Press Release, March 29, 2021]
-
(3.29) Advisory Committee Meeting Outcome on Janssen COVID-19 Vaccine.pdf
2021-03-30 -
-
56Pfizer COVID-19 Vaccine Comirnaty Lot Release Approved for 250,000 People [Press Release, March 28, 2021]
-
(3.28) Pfizer COVID-19 Vaccine Comirnaty Lot Release Approved for 250,000 People.pdf
2021-03-30 -
